HEADER TRANSPORT PROTEIN 30-OCT-08 3F3A TITLE CRYSTAL STRUCTURE OF LEUT BOUND TO L-TRYPTOPHAN AND SODIUM CAVEAT 3F3A BOG A 701 HAS WRONG CHIRALITY AT ATOM C2 BOG A 702 HAS WRONG CAVEAT 2 3F3A CHIRALITY AT ATOM C2 BOG A 703 HAS WRONG CHIRALITY AT ATOM CAVEAT 3 3F3A C2 BOG A 704 HAS WRONG CHIRALITY AT ATOM C2 BOG A 705 HAS CAVEAT 4 3F3A WRONG CHIRALITY AT ATOM C2 BOG A 706 HAS WRONG CHIRALITY AT CAVEAT 5 3F3A ATOM C2 BOG A 708 HAS WRONG CHIRALITY AT ATOM C2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSPORTER; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: LEUCINE TRANSPORTER; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: AQUIFEX AEOLICUS; SOURCE 3 ORGANISM_TAXID: 63363; SOURCE 4 STRAIN: VF5; SOURCE 5 GENE: SNF, AQ_2077; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: C41(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET16B KEYWDS SLC6, NSS, TRANSMEMBRANE, SODIUM-COUPLED, TRANSPORTER, SYMPORT, KEYWDS 2 TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.K.SINGH,C.L.PISCITELLI,A.YAMASHITA,E.GOUAUX REVDAT 4 06-SEP-23 3F3A 1 HETSYN REVDAT 3 29-JUL-20 3F3A 1 CAVEAT COMPND REMARK SEQADV REVDAT 3 2 1 HETNAM SITE REVDAT 2 10-MAR-09 3F3A 1 JRNL REVDAT 1 23-DEC-08 3F3A 0 JRNL AUTH S.K.SINGH,C.L.PISCITELLI,A.YAMASHITA,E.GOUAUX JRNL TITL A COMPETITIVE INHIBITOR TRAPS LEUT IN AN OPEN-TO-OUT JRNL TITL 2 CONFORMATION. JRNL REF SCIENCE V. 322 1655 2008 JRNL REFN ISSN 0036-8075 JRNL PMID 19074341 JRNL DOI 10.1126/SCIENCE.1166777 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.350 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 40334 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 2040 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.2461 - 4.9308 0.96 2586 141 0.2099 0.2248 REMARK 3 2 4.9308 - 3.9143 0.96 2544 140 0.1735 0.1629 REMARK 3 3 3.9143 - 3.4196 0.98 2554 128 0.1744 0.2130 REMARK 3 4 3.4196 - 3.1070 0.99 2605 139 0.1839 0.2287 REMARK 3 5 3.1070 - 2.8844 0.99 2581 136 0.1867 0.2439 REMARK 3 6 2.8844 - 2.7143 0.98 2580 123 0.1832 0.2408 REMARK 3 7 2.7143 - 2.5784 0.99 2554 147 0.1859 0.2121 REMARK 3 8 2.5784 - 2.4662 0.99 2550 143 0.1847 0.2418 REMARK 3 9 2.4662 - 2.3712 0.98 2551 138 0.1934 0.2464 REMARK 3 10 2.3712 - 2.2894 0.99 2563 141 0.2016 0.2628 REMARK 3 11 2.2894 - 2.2178 0.99 2597 124 0.2166 0.2664 REMARK 3 12 2.2178 - 2.1544 0.99 2563 140 0.2378 0.2823 REMARK 3 13 2.1544 - 2.0977 0.98 2567 135 0.2585 0.3094 REMARK 3 14 2.0977 - 2.0465 0.97 2459 148 0.2854 0.3304 REMARK 3 15 2.0465 - 2.0000 0.91 2440 117 0.2945 0.3295 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.31 REMARK 3 B_SOL : 50.00 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 41.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 NULL REMARK 3 ANGLE : 1.049 NULL REMARK 3 CHIRALITY : 0.069 NULL REMARK 3 PLANARITY : 0.005 NULL REMARK 3 DIHEDRAL : 18.628 NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3F3A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1000050092. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 8.2.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9796 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 41152 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.07 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.57700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2A65 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 0.4M NACL, 17-22% PEG-MME REMARK 280 550, PH 7.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 44.28300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.60900 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 44.28300 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 42.60900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 38650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -15.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 -83.78697 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -82.13508 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 612 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 VAL A 3 REMARK 465 LYS A 4 REMARK 465 PRO A 132 REMARK 465 ASN A 133 REMARK 465 ALA A 134 REMARK 465 SER A 512 REMARK 465 ALA A 513 REMARK 465 GLY A 514 REMARK 465 THR A 515 REMARK 465 LEU A 516 REMARK 465 VAL A 517 REMARK 465 PRO A 518 REMARK 465 ARG A 519 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 271 CG CD CE NZ REMARK 470 GLU A 470 CG CD OE1 OE2 REMARK 470 TYR A 471 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 54 -51.00 -124.48 REMARK 500 TRP A 85 92.64 -162.47 REMARK 500 PRO A 160 44.38 -81.04 REMARK 500 ILE A 297 -77.29 -99.06 REMARK 500 ILE A 325 -56.32 -121.73 REMARK 500 LYS A 398 -0.64 76.37 REMARK 500 THR A 409 -75.86 -127.97 REMARK 500 TYR A 454 -52.20 -122.99 REMARK 500 VAL A 465 -76.55 -80.32 REMARK 500 TYR A 471 -54.44 -127.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2A65 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-LEUCINE AND SODIUM REMARK 900 RELATED ID: 2QEI RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH L-ALANINE, SODIUM, AND CLOMIPRAMINE REMARK 900 RELATED ID: 3F3C RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO 4-FLUORO-L-PHENYLALANINE AND REMARK 900 SODIUM REMARK 900 RELATED ID: 3F3D RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-METHIONINE AND SODIUM REMARK 900 RELATED ID: 3F3E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-LEUCINE(30 MM) AND SODIUM REMARK 900 RELATED ID: 3F48 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-ALANINE AND SODIUM REMARK 900 RELATED ID: 3F4I RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO L-SELENOMETHIONINE AND SODIUM REMARK 900 RELATED ID: 3F4J RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF LEUT BOUND TO GLYCINE AND SODIUM DBREF 3F3A A 1 513 UNP O67854 O67854_AQUAE 1 513 SEQADV 3F3A GLY A 514 UNP O67854 EXPRESSION TAG SEQADV 3F3A THR A 515 UNP O67854 EXPRESSION TAG SEQADV 3F3A LEU A 516 UNP O67854 EXPRESSION TAG SEQADV 3F3A VAL A 517 UNP O67854 EXPRESSION TAG SEQADV 3F3A PRO A 518 UNP O67854 EXPRESSION TAG SEQADV 3F3A ARG A 519 UNP O67854 EXPRESSION TAG SEQRES 1 A 519 MET GLU VAL LYS ARG GLU HIS TRP ALA THR ARG LEU GLY SEQRES 2 A 519 LEU ILE LEU ALA MET ALA GLY ASN ALA VAL GLY LEU GLY SEQRES 3 A 519 ASN PHE LEU ARG PHE PRO VAL GLN ALA ALA GLU ASN GLY SEQRES 4 A 519 GLY GLY ALA PHE MET ILE PRO TYR ILE ILE ALA PHE LEU SEQRES 5 A 519 LEU VAL GLY ILE PRO LEU MET TRP ILE GLU TRP ALA MET SEQRES 6 A 519 GLY ARG TYR GLY GLY ALA GLN GLY HIS GLY THR THR PRO SEQRES 7 A 519 ALA ILE PHE TYR LEU LEU TRP ARG ASN ARG PHE ALA LYS SEQRES 8 A 519 ILE LEU GLY VAL PHE GLY LEU TRP ILE PRO LEU VAL VAL SEQRES 9 A 519 ALA ILE TYR TYR VAL TYR ILE GLU SER TRP THR LEU GLY SEQRES 10 A 519 PHE ALA ILE LYS PHE LEU VAL GLY LEU VAL PRO GLU PRO SEQRES 11 A 519 PRO PRO ASN ALA THR ASP PRO ASP SER ILE LEU ARG PRO SEQRES 12 A 519 PHE LYS GLU PHE LEU TYR SER TYR ILE GLY VAL PRO LYS SEQRES 13 A 519 GLY ASP GLU PRO ILE LEU LYS PRO SER LEU PHE ALA TYR SEQRES 14 A 519 ILE VAL PHE LEU ILE THR MET PHE ILE ASN VAL SER ILE SEQRES 15 A 519 LEU ILE ARG GLY ILE SER LYS GLY ILE GLU ARG PHE ALA SEQRES 16 A 519 LYS ILE ALA MET PRO THR LEU PHE ILE LEU ALA VAL PHE SEQRES 17 A 519 LEU VAL ILE ARG VAL PHE LEU LEU GLU THR PRO ASN GLY SEQRES 18 A 519 THR ALA ALA ASP GLY LEU ASN PHE LEU TRP THR PRO ASP SEQRES 19 A 519 PHE GLU LYS LEU LYS ASP PRO GLY VAL TRP ILE ALA ALA SEQRES 20 A 519 VAL GLY GLN ILE PHE PHE THR LEU SER LEU GLY PHE GLY SEQRES 21 A 519 ALA ILE ILE THR TYR ALA SER TYR VAL ARG LYS ASP GLN SEQRES 22 A 519 ASP ILE VAL LEU SER GLY LEU THR ALA ALA THR LEU ASN SEQRES 23 A 519 GLU LYS ALA GLU VAL ILE LEU GLY GLY SER ILE SER ILE SEQRES 24 A 519 PRO ALA ALA VAL ALA PHE PHE GLY VAL ALA ASN ALA VAL SEQRES 25 A 519 ALA ILE ALA LYS ALA GLY ALA PHE ASN LEU GLY PHE ILE SEQRES 26 A 519 THR LEU PRO ALA ILE PHE SER GLN THR ALA GLY GLY THR SEQRES 27 A 519 PHE LEU GLY PHE LEU TRP PHE PHE LEU LEU PHE PHE ALA SEQRES 28 A 519 GLY LEU THR SER SER ILE ALA ILE MET GLN PRO MET ILE SEQRES 29 A 519 ALA PHE LEU GLU ASP GLU LEU LYS LEU SER ARG LYS HIS SEQRES 30 A 519 ALA VAL LEU TRP THR ALA ALA ILE VAL PHE PHE SER ALA SEQRES 31 A 519 HIS LEU VAL MET PHE LEU ASN LYS SER LEU ASP GLU MET SEQRES 32 A 519 ASP PHE TRP ALA GLY THR ILE GLY VAL VAL PHE PHE GLY SEQRES 33 A 519 LEU THR GLU LEU ILE ILE PHE PHE TRP ILE PHE GLY ALA SEQRES 34 A 519 ASP LYS ALA TRP GLU GLU ILE ASN ARG GLY GLY ILE ILE SEQRES 35 A 519 LYS VAL PRO ARG ILE TYR TYR TYR VAL MET ARG TYR ILE SEQRES 36 A 519 THR PRO ALA PHE LEU ALA VAL LEU LEU VAL VAL TRP ALA SEQRES 37 A 519 ARG GLU TYR ILE PRO LYS ILE MET GLU GLU THR HIS TRP SEQRES 38 A 519 THR VAL TRP ILE THR ARG PHE TYR ILE ILE GLY LEU PHE SEQRES 39 A 519 LEU PHE LEU THR PHE LEU VAL PHE LEU ALA GLU ARG ARG SEQRES 40 A 519 ARG ASN HIS GLU SER ALA GLY THR LEU VAL PRO ARG HET TRP A 601 15 HET TRP A 602 15 HET TRP A 603 15 HET TRP A 604 15 HET BOG A 701 20 HET BOG A 702 20 HET BOG A 703 20 HET BOG A 704 20 HET BOG A 705 20 HET BOG A 706 20 HET C14 A 707 14 HET BOG A 708 20 HET NA A 751 1 HET NA A 752 1 HETNAM TRP TRYPTOPHAN HETNAM BOG OCTYL BETA-D-GLUCOPYRANOSIDE HETNAM C14 TETRADECANE HETNAM NA SODIUM ION HETSYN BOG BETA-OCTYLGLUCOSIDE; OCTYL BETA-D-GLUCOSIDE; OCTYL D- HETSYN 2 BOG GLUCOSIDE; OCTYL GLUCOSIDE FORMUL 2 TRP 4(C11 H12 N2 O2) FORMUL 6 BOG 7(C14 H28 O6) FORMUL 12 C14 C14 H30 FORMUL 14 NA 2(NA 1+) FORMUL 16 HOH *101(H2 O) HELIX 1 1 THR A 10 VAL A 23 1 14 HELIX 2 2 GLY A 24 LEU A 29 1 6 HELIX 3 3 LEU A 29 ASN A 38 1 10 HELIX 4 4 GLY A 39 ALA A 42 5 4 HELIX 5 5 PHE A 43 VAL A 54 1 12 HELIX 6 6 VAL A 54 GLN A 72 1 19 HELIX 7 7 THR A 76 TRP A 85 1 10 HELIX 8 8 ASN A 87 GLY A 125 1 39 HELIX 9 9 ASP A 136 GLY A 153 1 18 HELIX 10 10 SER A 165 ILE A 184 1 20 HELIX 11 11 ARG A 185 GLY A 190 1 6 HELIX 12 12 GLY A 190 LEU A 216 1 27 HELIX 13 13 ALA A 223 THR A 232 1 10 HELIX 14 14 ASP A 234 LYS A 239 5 6 HELIX 15 15 ASP A 240 LEU A 255 1 16 HELIX 16 16 GLY A 260 SER A 267 1 8 HELIX 17 17 ILE A 275 ILE A 292 1 18 HELIX 18 18 ILE A 297 GLY A 307 1 11 HELIX 19 19 ASN A 310 ALA A 317 1 8 HELIX 20 20 GLY A 318 ILE A 325 1 8 HELIX 21 21 ILE A 325 SER A 332 1 8 HELIX 22 22 GLY A 336 LYS A 372 1 37 HELIX 23 23 SER A 374 LEU A 396 1 23 HELIX 24 24 LYS A 398 ALA A 407 1 10 HELIX 25 25 THR A 409 TRP A 425 1 17 HELIX 26 26 GLY A 428 ARG A 438 1 11 HELIX 27 27 ILE A 447 TYR A 454 1 8 HELIX 28 28 TYR A 454 GLU A 470 1 17 HELIX 29 29 TYR A 471 GLU A 478 1 8 HELIX 30 30 THR A 482 GLU A 511 1 30 SHEET 1 A 2 GLU A 217 THR A 218 0 SHEET 2 A 2 GLY A 221 THR A 222 -1 O GLY A 221 N THR A 218 CISPEP 1 PRO A 130 PRO A 131 0 1.87 CRYST1 88.566 85.218 82.274 90.00 93.33 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011291 0.000000 0.000657 0.00000 SCALE2 0.000000 0.011735 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012175 0.00000